Individuals on immunosuppressants should discontinue them prior to patch testing, if at all possible, to avoid tarnishing the test results, according to updated guidelines from the North American ...

Aclaris Therapeutics, Inc. (NASDAQ: ACRS) has announced significant findings about ATI-2138, a novel investigational drug ...

Data Generated to Date Support Potential for Aclaris’ ATI-2138 to Impact Several Human Inflammatory Diseases -WAYNE, Pa., Feb. 12, 2025 ...

Incyte (NASDAQ:INCY – Free Report) had its price objective hoisted by Stifel Nicolaus from $75.00 to $77.00 in a report released on Monday morning,Benzinga reports. Stifel Nicolaus currently has a ...

Here’s how it works. Trying to work out what the best VPN for you is can be a real headache. Because there's so much information out there, it can be difficult to know what to trust. I've taken ...